Epigenomics of Common Diseases (Virtual Conference)

Single Cell Biology virtual conference logo
18 November, 2020 - 20 November, 2020


Deadline: 11/11/2020
Click here to register

General Information

We are pleased to announce the 9th Epigenomics of Common Diseases conference and invite scientists working on experimental and computational epigenomics and epigenetics to showcase the latest developments in the field and discuss epigenomic approaches in common human diseases.

Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference maps, including populational and environmental epigenomic datasets.

The conference will cover a broad spectrum of epigenomic discoveries, opportunities and challenges in human normal biology and in disease. This year’s topics include epigenetic classifiers, chromatin regulation in disease, population studies and multi ’omics’ epigenomics. We will highlight methodologies such as single cell sequencing and new bioinformatics approaches  and also discuss reference annotation of epigenomes.

The conference will start at approximately 1 pm (GMT) on Wednesday 18 November and close at approximately 7 pm on Friday 20 November 2020. All times are given in Greenwich Mean Time. See the time where you are here.

Topics will include:

  • Single cell & technology
  • Epigenetic classifiers
  • Chromatin regulation in disease
  • Population studies
  • Multi ‘omics’ and integrative epigenomics
  • Reference annotation


Confirmed speakers

Kelly Bakulski – University of Michigan, USA
David Capper – Charité, Germany
Christopher Glass – University of California San Diego, USA
Martin Hirst – University of British Columbia, Canada
Claudia Kleinman – McGill University, Canada
Tuuli Lappalainen – New York Genome Center & Columbia University USA
Riccardo Marioni – University of Edinburgh, UK
Alex Meissner – Max Planck Institute for Molecular Genetics, Germany
Gemma Sharp – University of Bristol, UK
Sarah Teichmann – Wellcome Sanger Institute
Céline Vallot – Institut Curie, France
Naomi Wray – University of Queensland, Australia